Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

Alzheimer’s image

Alzheimer’s research ‘turning point’

October 11, 2013
Research and Development, Sales and Marketing Alzheimer's, Alzheimer’s, MRC, research

There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …

News
lundbeck image

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013
Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …

News
Brain scan image

Dementia rates declining in UK

July 17, 2013
Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …

News
lilly image

Lilly revisits Alzheimer’s drug

July 15, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …

News
lilly_scientists

Lilly increases Alzheimer’s R&D

April 18, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …

News
merck image

Merck makes Alzheimer’s deal

March 14, 2013
Research and Development, Sales and Marketing Alzheimer's, Merck

Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …

News
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013
Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

News
janssen image

Alzheimer’s drug lowers mortality

December 7, 2012
Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly

A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …

News
lilly corporate hq image

New drugs for Alzheimer’s trial

October 15, 2012
Research and Development, Sales and Marketing Alzheimer's, Roche, lilly

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

News
lilly_corporate_hq

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012
Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …

News
Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …

News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …

News

AZ sets up Alzheimer’s research collaborative

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …

News
astrazeneca image

AstraZeneca buys neuroscience molecules

July 13, 2012
Research and Development Alzheimer's, AstraZeneca, neuroscience

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …

News
Alzheimer's brain

MPs warn of dementia delays

July 3, 2012
Research and Development, Sales and Marketing APPG, Alzheimer's, dementia, government

Patients with dementia are facing huge delays in their diagnosis and treatment according to a group of MPs and peers. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025